[Glucose-insulin-potassium (GIK) in the reduction of acute myocardial ischemia after an aortocoronary bypass intervention].
Dainese
L
L
Cattedra di Cardiochirurgia, Università degli Studi di Milano, Centro Cardiologico Fondazione Monzino, IRCCS.
Polvani
G L
GL
Fumero
A
A
Spirito
R
R
Alamanni
F
F
Agrifoglio
M
M
Parolari
A
A
Biglioli
P
P
D000208:Acute Disease; D000818:Animals; D002314:Cardioplegic Solutions / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D004734:Energy Metabolism / Q000187:drug effects; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D011183:Postoperative Complications / Q000188:drug therapy* / Q000378:metabolism; D011188:Potassium / Q000627:therapeutic use
D002314:Cardioplegic Solutions; D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D005947:Glucose; D011188:Potassium
Glucosio-insulina-potassio (GIK) nella riduzione dell'ischemia miocardica acuta dopo intervento di bypass aortocoronarico.